The University of Alabama at Birmingham Department of Obstetrics and Gynecology and the Department of Biostatistics have been awarded a $19.31 million R01 grant by the National Institutes of Health’s Heart, Lung and Blood Institute to coordinate the most comprehensive study of chronic hypertension in pregnancy ever undertaken.
The Chronic Hypertension and Pregnancy Project (CHAP) is a multicenter, randomized trial which will enroll between 4,700 and 5,700 pregnant women during the next six years with a primary aim to evaluate the benefits and potential harms of pharmacologic treatment of mild chronic hypertension in pregnancy. Alan Tita, M.D., Ph.D., Professor of Obstetrics and Gynecology in UAB’s School of Medicine is principal investigator/project director for CHAP. UAB Media Contact: Tyler Greer | firstname.lastname@example.org
UAB has enrolled the first U.S. patient in a Phase III clinical trial for a drug that, if successful, would be a significant clinical breakthrough for reducing pre-term births and infant mortality. Alan Tita, M.D., Ph.D., professor of Obstetrics and Gynecology is lead investigator for the trial.
May 2012 - Huh Receives Distinguished 2012 ACS Lane Adams Quality of Life Award - Dr. Huh has been named a recipient of the American Cancer Society 2012 Lane W. Adams Quality of Life Award. He is one of 11 cancer-care providers nationwide who will be honored in a ceremony on Thursday, May 3, 2012, during the ACS annual board meeting in Dallas.The award recognizes individuals who have made a difference through innovation, leadership and consistent excellence in providing compassionate, skilled care and counsel to persons living with cancer and their families. Recipients are nominated by patients and their families, shedding light on the critical role that outstanding caregivers play in the healing process. UAB News Media Contact: Beena Thannickal, (205) 975-3967, email@example.com